US Stock MarketDetailed Quotes

ImmunityBio (IBRX)

Watchlist
  • 7.280
  • -0.200-2.67%
Close Apr 10 16:00 ET
  • 7.270
  • -0.010-0.14%
Post 20:01 ET
7.52BMarket Cap-19.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ImmunityBio (IBRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
668.31%113.29M
406.95%38.29M
425.07%32.06M
2,423.88%26.43M
41,192.50%16.52M
2,270.58%14.75M
5,333.09%7.55M
7,346.34%6.11M
2,453.66%1.05M
-88.89%40K
Operating revenue
698.46%112.98M
431.11%38.27M
433.76%31.78M
2,568.79%26.42M
--16.51M
--14.15M
--7.21M
--5.95M
--990K
--0
Cost of revenue
753K
382K
177K
136K
58K
0
0
0
0
0
Gross profit
663.21%112.54M
401.89%37.9M
422.17%31.88M
2,410.89%26.29M
41,047.50%16.46M
2,270.58%14.75M
5,333.09%7.55M
7,346.34%6.11M
2,453.66%1.05M
40K
Operating expense
2.68%368.56M
33.31%102.59M
1.34%87.51M
-2.80%97.57M
-15.07%80.89M
-0.85%358.93M
-9.09%76.95M
7.66%86.36M
17.84%100.38M
-14.92%95.24M
Selling and administrative expenses
-11.13%150M
-7.19%38.73M
1.02%36.28M
-14.04%42.34M
-22.04%32.65M
30.21%168.78M
26.04%41.73M
12.89%35.92M
53.82%49.25M
28.18%41.89M
Research and development costs
14.94%218.56M
81.30%63.86M
1.56%51.23M
8.03%55.24M
-9.59%48.23M
-18.17%190.14M
-31.65%35.22M
4.22%50.44M
-3.84%51.13M
-32.69%53.35M
Operating profit
25.61%-256.03M
6.80%-64.68M
30.68%-55.63M
28.24%-71.29M
32.32%-64.43M
4.75%-344.18M
17.87%-69.4M
-0.15%-80.25M
-16.66%-99.33M
14.68%-95.2M
Net non-operating interest income expense
27.70%-109.84M
27.69%-26.61M
32.31%-26.81M
26.50%-28.07M
24.06%-28.35M
-18.38%-151.93M
-12.38%-36.81M
-15.11%-39.61M
-20.68%-38.19M
-26.40%-37.33M
Non-operating interest income
12.04%2.69M
-24.71%579K
21.00%772K
-1.80%818K
225.00%520K
178.10%2.4M
223.43%769K
4.59%638K
40.71%833K
-43.66%160K
Non-operating interest expense
-14.59%112.53M
81.44%27.19M
-31.46%27.58M
-25.97%28.88M
-9.62%28.87M
51.77%131.74M
245.94%14.99M
14.92%40.25M
21.05%39.02M
7.12%31.94M
Total other finance cost
----
----
----
----
----
-46.72%22.59M
----
----
----
--5.55M
Other net income (expense)
-82.71%14.26M
-37.90%29.2M
-55.63%15.13M
140.07%7.05M
-2,210.27%-37.13M
187.55%82.46M
140.47%47.03M
80.43%34.11M
113.70%2.94M
-106.55%-1.61M
Gain on sale of security
51.78%59.2M
776.47%31.06M
-51.64%16.49M
108.50%6.16M
446.38%5.5M
182.41%39.01M
104.53%3.54M
149.07%34.1M
127.66%2.95M
-105.68%-1.59M
Earnings from equity interest
--0
----
----
----
----
--0
--0
--0
--0
--0
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-203.43%-44.95M
-104.28%-1.86M
-11,400.00%-1.36M
5,341.18%891K
-213,015.00%-42.62M
213.09%43.46M
217.45%43.48M
-99.81%12K
99.75%-17K
98.14%-20K
Income before tax
15.00%-351.61M
-4.92%-62.09M
21.51%-67.31M
31.41%-92.31M
3.15%-129.9M
29.16%-413.65M
74.65%-59.18M
10.34%-85.75M
2.63%-134.58M
-15.05%-134.13M
Income tax
-135K
-135K
-35K
269K
-234K
0
0
0
0
0
Net income
15.03%-351.47M
-4.70%-61.96M
21.55%-67.27M
31.21%-92.57M
3.33%-129.67M
29.15%-413.65M
74.65%-59.18M
10.34%-85.75M
2.63%-134.58M
-15.05%-134.13M
Net income continuous Operations
15.03%-351.47M
-4.70%-61.96M
21.55%-67.27M
31.21%-92.57M
3.33%-129.67M
29.15%-413.65M
74.65%-59.18M
10.34%-85.75M
2.63%-134.58M
-15.05%-134.13M
Minority interest income
8.64%-74K
17.65%-14K
8.70%-21K
5.00%-19K
4.76%-20K
87.65%-81K
22.73%-17K
61.67%-23K
94.01%-20K
91.25%-21K
Net income attributable to the parent company
15.03%-351.4M
-4.70%-61.94M
21.55%-67.25M
31.22%-92.56M
3.33%-129.65M
29.09%-413.56M
74.65%-59.16M
10.31%-85.73M
2.40%-134.56M
-15.27%-134.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.03%-351.4M
-4.70%-61.94M
21.55%-67.25M
31.22%-92.56M
3.33%-129.65M
29.09%-413.56M
74.65%-59.16M
10.31%-85.73M
2.40%-134.56M
-15.27%-134.11M
Basic earnings per share
35.59%-0.38
25.00%-0.06
41.67%-0.07
50.00%-0.1
25.00%-0.15
48.70%-0.59
78.95%-0.08
36.84%-0.12
37.50%-0.2
25.93%-0.2
Diluted earnings per share
38.71%-0.38
33.33%-0.06
50.00%-0.07
50.00%-0.1
25.00%-0.15
46.09%-0.62
76.32%-0.09
26.32%-0.14
37.50%-0.2
25.93%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 668.31%113.29M406.95%38.29M425.07%32.06M2,423.88%26.43M41,192.50%16.52M2,270.58%14.75M5,333.09%7.55M7,346.34%6.11M2,453.66%1.05M-88.89%40K
Operating revenue 698.46%112.98M431.11%38.27M433.76%31.78M2,568.79%26.42M--16.51M--14.15M--7.21M--5.95M--990K--0
Cost of revenue 753K382K177K136K58K00000
Gross profit 663.21%112.54M401.89%37.9M422.17%31.88M2,410.89%26.29M41,047.50%16.46M2,270.58%14.75M5,333.09%7.55M7,346.34%6.11M2,453.66%1.05M40K
Operating expense 2.68%368.56M33.31%102.59M1.34%87.51M-2.80%97.57M-15.07%80.89M-0.85%358.93M-9.09%76.95M7.66%86.36M17.84%100.38M-14.92%95.24M
Selling and administrative expenses -11.13%150M-7.19%38.73M1.02%36.28M-14.04%42.34M-22.04%32.65M30.21%168.78M26.04%41.73M12.89%35.92M53.82%49.25M28.18%41.89M
Research and development costs 14.94%218.56M81.30%63.86M1.56%51.23M8.03%55.24M-9.59%48.23M-18.17%190.14M-31.65%35.22M4.22%50.44M-3.84%51.13M-32.69%53.35M
Operating profit 25.61%-256.03M6.80%-64.68M30.68%-55.63M28.24%-71.29M32.32%-64.43M4.75%-344.18M17.87%-69.4M-0.15%-80.25M-16.66%-99.33M14.68%-95.2M
Net non-operating interest income expense 27.70%-109.84M27.69%-26.61M32.31%-26.81M26.50%-28.07M24.06%-28.35M-18.38%-151.93M-12.38%-36.81M-15.11%-39.61M-20.68%-38.19M-26.40%-37.33M
Non-operating interest income 12.04%2.69M-24.71%579K21.00%772K-1.80%818K225.00%520K178.10%2.4M223.43%769K4.59%638K40.71%833K-43.66%160K
Non-operating interest expense -14.59%112.53M81.44%27.19M-31.46%27.58M-25.97%28.88M-9.62%28.87M51.77%131.74M245.94%14.99M14.92%40.25M21.05%39.02M7.12%31.94M
Total other finance cost ---------------------46.72%22.59M--------------5.55M
Other net income (expense) -82.71%14.26M-37.90%29.2M-55.63%15.13M140.07%7.05M-2,210.27%-37.13M187.55%82.46M140.47%47.03M80.43%34.11M113.70%2.94M-106.55%-1.61M
Gain on sale of security 51.78%59.2M776.47%31.06M-51.64%16.49M108.50%6.16M446.38%5.5M182.41%39.01M104.53%3.54M149.07%34.1M127.66%2.95M-105.68%-1.59M
Earnings from equity interest --0------------------0--0--0--0--0
Special income (charges) --0------------------0----------------
-Less:Impairment of capital assets --0------------------0----------------
Other non- operating income (expenses) -203.43%-44.95M-104.28%-1.86M-11,400.00%-1.36M5,341.18%891K-213,015.00%-42.62M213.09%43.46M217.45%43.48M-99.81%12K99.75%-17K98.14%-20K
Income before tax 15.00%-351.61M-4.92%-62.09M21.51%-67.31M31.41%-92.31M3.15%-129.9M29.16%-413.65M74.65%-59.18M10.34%-85.75M2.63%-134.58M-15.05%-134.13M
Income tax -135K-135K-35K269K-234K00000
Net income 15.03%-351.47M-4.70%-61.96M21.55%-67.27M31.21%-92.57M3.33%-129.67M29.15%-413.65M74.65%-59.18M10.34%-85.75M2.63%-134.58M-15.05%-134.13M
Net income continuous Operations 15.03%-351.47M-4.70%-61.96M21.55%-67.27M31.21%-92.57M3.33%-129.67M29.15%-413.65M74.65%-59.18M10.34%-85.75M2.63%-134.58M-15.05%-134.13M
Minority interest income 8.64%-74K17.65%-14K8.70%-21K5.00%-19K4.76%-20K87.65%-81K22.73%-17K61.67%-23K94.01%-20K91.25%-21K
Net income attributable to the parent company 15.03%-351.4M-4.70%-61.94M21.55%-67.25M31.22%-92.56M3.33%-129.65M29.09%-413.56M74.65%-59.16M10.31%-85.73M2.40%-134.56M-15.27%-134.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.03%-351.4M-4.70%-61.94M21.55%-67.25M31.22%-92.56M3.33%-129.65M29.09%-413.56M74.65%-59.16M10.31%-85.73M2.40%-134.56M-15.27%-134.11M
Basic earnings per share 35.59%-0.3825.00%-0.0641.67%-0.0750.00%-0.125.00%-0.1548.70%-0.5978.95%-0.0836.84%-0.1237.50%-0.225.93%-0.2
Diluted earnings per share 38.71%-0.3833.33%-0.0650.00%-0.0750.00%-0.125.00%-0.1546.09%-0.6276.32%-0.0926.32%-0.1437.50%-0.225.93%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -